$7.790
-0.224 (-2.87%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
BioCryst Pharmaceuticals, Inc. (BCRX) Moving Averages Convergence Divergence (MACD) indicator is -0.24, suggesting BCRX is Strong sell.
BioCryst Pharmaceuticals, Inc. (BCRX) 20-Day simple moving average is 8.27, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $—, making it Sell.
BioCryst Pharmaceuticals, Inc. (BCRX) 60-Day simple moving average is 9.02, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $—, making it Sell.
Technical Analysis for BCRX
AI Technical BCRXAs of 2026-10-17, the technical board for BioCryst Pharmaceuticals, Inc. (BCRX) reads strong sell: 1 indicators are flashing buy, 8 are indicating sell, and 4 are neutral. Price at $8.07 sits below the 10-day, 20-day, 60-day and 200-day moving averages and above the 5-day.
Momentum readings: RSI stands at 42.622, MACD stands at -0.241 (Sell), Stochastic %K stands at 21.481, Stochastic %D stands at 20.449 and CCI stands at -97.008.
BCRX trades below the 60-day SMA (9.02) and below the 200-day SMA (8.71). Immediate resistance sits at Classic R1 8.59, then R2 9.02. Support sits at Classic S1 7.73, then S2 7.31.
BioCryst Pharmaceuticals, Inc. (BCRX) Support & Resistance Level
BioCryst Pharmaceuticals, Inc. (BCRX) Technical Indicators
2026-10-17
| Name | Value |
|---|---|
| RSI_14 | 42.622 |
| STOCHk_14_3_3 | 21.481 |
| STOCHd_14_3_3 | 20.449 |
| CCI_20 | -97.008 |
| AO_5_34 | -0.517 |
| MOM_10 | -0.030 |
| MACD_12_26_9 | -0.241 |
BioCryst Pharmaceuticals, Inc. (BCRX) Relative Strength Index (RSI_14) is 42.622, creating a Neutral signal.
BioCryst Pharmaceuticals, Inc. (BCRX) Stochastic %K is 21.481, creating a Neutral signal.
BioCryst Pharmaceuticals, Inc. (BCRX) Stochastic %D is 20.449, creating a Neutral signal.
BioCryst Pharmaceuticals, Inc. (BCRX) CCI_20 is -97.008, creating a Neutral signal.
BioCryst Pharmaceuticals, Inc. (BCRX) Awesome Oscillator (AO) is -0.517, creating a Sell signal.
BioCryst Pharmaceuticals, Inc. (BCRX) Momentum (MOM) is -0.030, creating a Sell signal.
BioCryst Pharmaceuticals, Inc. (BCRX) Moving Average Convergence Divergence (MACD) is -0.241, creating a Sell signal.
BioCryst Pharmaceuticals, Inc. (BCRX) Moving Average
2026-10-17
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 8.000 | Buy |
| MA_10 | 8.155 | Sell |
| MA_20 | 8.274 | Sell |
| MA_60 | 9.024 | Sell |
| MA_200 | 8.715 | Sell |
| MA_250 | 8.430 | Sell |
BioCryst Pharmaceuticals, Inc. (BCRX) 5-Day simple moving average is 8.000, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $, making it a Buy.
BioCryst Pharmaceuticals, Inc. (BCRX) 10-Day simple moving average is 8.155, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $, making it a Sell.
BioCryst Pharmaceuticals, Inc. (BCRX) 20-Day simple moving average is 8.274, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $, making it a Sell.
BioCryst Pharmaceuticals, Inc. (BCRX) 60-Day simple moving average is 9.024, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $, making it a Sell.
BioCryst Pharmaceuticals, Inc. (BCRX) 200-Day simple moving average is 8.715, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $, making it a Sell.
BioCryst Pharmaceuticals, Inc. (BCRX) 250-Day simple moving average is 8.430, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.